Jiangsu CoWin Biotech Co., Ltd.

¥18.06As of Sun 8 Nov 2026, 12:00 UTC
SSE:688426Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (15.31%)
Div yield —
ROE (6.11%)
Biotechnology
Beta (5Y) 0.88
PE TTM —
TSR TTM (37.10%)
Mkt cap ¥1.985B
ROIC (14.82%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥21
18.46%
(62.02%)
Hold 6|4|1|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.25
0.23
0.26
0.28
8.25%
4.73%
4.97%
15.94%
Revenue¥M
96.50
99.54
99.93
97.68
0.10%
(0.31%)
(2.08%)
(1.68%)
Peers (US$297.6M)
Cap (US$)
PE
301.1M
76.93x
297.5M
—
Capital
TTM
5Y
10Y
Leveragex
2.557
2.606
1.923
EBIT/Intx
2.022
0.410
0.399
Own earn%
(159.34)
(53.22)
(66.87)
Sh yield%
31.91
18.62
16.29
Owners
Insiders/Inst%
5.58
34.85
Short interest%
5.96
SBC / revenue%
2.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
16–23
$1 testx
0.1
Incr. ROIC%
2